PPT-Safety Concerns With Insulin Use

in the Inpatient Setting The Pharmacists Role 1 Pharmacists Role in the Safe Use of Insulin in the Inpatient Setting Minimizing medication errors Discouraging the use of sliding scale insulin. These devices are designed to permit self injection and are intended for single person use In healthcare settings these devices are often used by healthcare personnel to administer insulin to patients Insulin pens are designed to be used multiple t *. Stephen W. Ponder MD, FAAP, CDE. Scott & White Clinic. Temple, Round Rock and College Station. *. . And a bunch of other important stuff. One goal of diabetes care is managing glucose…. FLUX. Prof. dr. . Zoran. . Vali. ć. Department of Physiology. University of Split School of Medicine. digestive functions. two important hormones: insulin and glucagon . (. crucial for normal regulation of glucose, lipid, and protein metabolism. Presented by:. Jo Greengrass, Deputy Director of Nursing, Quality & Safety. Simon Hawkins, Quality Improvement Support Manager. A Brief Background. Since July 2013 Clinical Concerns has dealt with over . the Treatment of T1DM and T2DM. Lawrence Blonde, MD, FACP, FACE. Director of the . Ochsner. Diabetes Clinical Research Unit. Ochsner. Medical Center. New Orleans, Louisiana. Vivian . A. Fonseca, MD, FRCP. First Steps in Identification and Referral. Wayla Murrow, Technical Assistance and Outreach Coordinator, Early Intervention Colorado . Moniqua. Herrington, Training Coordinator, Early Intervention Colorado. R. esistance and Diabetes. Alfred Martello, MD. Medical Director. The Ohio Anesthesia Group. Disclosures. No Commercial endorsements. I’m not really smart enough to give this lecture.. It’s really complicated stuff.. . David Beran. Researcher and Lecturer. University of Geneva. Multi-level assessment of Health system. Macro. Ministry of Health . Ministry of Trade. Ministry of Finance. Central Medical Store. National Diabetes Association. . David Beran. Researcher and Lecturer. University of Geneva. Multi-level assessment of Health system. Macro. Ministry of Health . Ministry of Trade. Ministry of Finance. Central Medical Store. National Diabetes Association. Pharmacoepidemiology and Drug Safety. 2008;(17):753-759.. So benefit of both SU/Insulin in. research studies –UKPDS, DCCT/EDIC. But adverse risk in ‘real world’ use. Link between hypoglycemia and acute cardiovascular events in type 2 diabetes. TOP 3 HR COMPLIANCE CONCERNS ALL BUSINESSES SHOULD WORRY ABOUT Sabrina Baker, SHRM-CP • CEO/Founder 01 A little about me... Sabrina Baker, SHRM-CP CEO, Acacia HR Solutions sabrina@acaciahrsolutions.com 71Introduction the need for a communication policyManagement of groundwater affects many different aspects of social development and well-being7 Public concerns and risk communicationinvolved the pub outthisreview Alberta Insulin Pump Therapy Program: Introduction to Insulin Pump Therapy Questionnaire Nov 2016 Bolusinsulinsugarreadingsdeliveredpumpsfingerreadings.DKAhighinsulinsomeonepumpDKA: Albe Markus Menzen. 1. ; Niels Væver Hartvig. 2. ; Anne Kaas. 2. ; Nikoline Nygård Knudsen. 2. ; Johan Jendle. 3. 1. Division of Internal Medicine, Department of Gastroenterology and Diabetology, Community Hospital Bonn, Bonn, Germany.